Progenics Pharmaceuticals Inc (PGNX.OQ)

PGNX.OQ on NASDAQ Stock Exchange Global Select Market

5.22USD
4:00pm EDT
Price Change (% chg)

$-0.10 (-1.88%)
Prev Close
$5.32
Open
$5.39
Day's High
$5.40
Day's Low
$5.16
Volume
218,442
Avg. Vol
268,213
52-wk High
$7.45
52-wk Low
$3.15

PGNX.OQ

Chart for PGNX.OQ

About

Progenics Pharmaceuticals, Inc. (Progenics) is a biopharmaceutical company focuses on research and development for biotechnology product candidates in oncology, virology, supportive care and gastroenterology. It is also engaged in research to identify multiplex phosphoinositide 3-kinase inhibitors for blocking signaling pathways... (more)

Overall

Beta: 1.52
Market Cap (Mil.): $370.04
Shares Outstanding (Mil.): 69.56
Dividend: --
Yield (%): --

Financials

  PGNX.OQ Industry Sector
P/E (TTM): -- 32.66 33.47
EPS (TTM): -0.63 -- --
ROI: -31.70 18.15 17.39
ROE: -41.62 18.86 18.25
Search Stocks

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: New Constructs, LLC
$25.00
Provider: S&P Capital IQ Quantitative Report
$127.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks